talent manufacturing
Pharma Layoffs and the Pharmaceutical Industry Outlook: Why Job Cuts Continue Despite Market Growth
April Stanley, MS MBA; David Alvaro, Ph.D.
Nice Insight
NI-9-26-MA53Sep 4, 2026
talent manufacturing
Global Talent Shortage
April Stanley, MS MBA; Koey Keylon
Nice Insight
NI-9-26-MA52Sep 4, 2026
mRNA / analytical
The mRNA Therapeutics Analytical Landscape
David Alvaro, Ph.D.; April Stanley, MS MBA
Pharma's Almanac
NI-8-26-MA3Aug 28, 2026
cell therapy
Core Analytical Frameworks in Cell Therapy Quality Control
April Stanley, MS MBA
Nice Insight
NI-8-26-MA38Aug 28, 2026
small molecules
Small Molecule Discovery and Development Trends
David Alvaro, Ph.D.
Pharma's Almanac
NI-8-26-MA50Aug 28, 2026
antibodies
Key Technologies Used in Manufacturing Antibodies
David Alvaro, Ph.D.; April Stanley, MS MBA
Pharma's Almanac
NI-8-26-MA11Aug 28, 2026
OSD
Oral Solid Dose Manufacturing Basics
April Stanley, MS MBA
Nice Insight
NI-8-26-MA12Aug 28, 2026
Market Drivers
Small Molecule API Manufacturing Trends
David Alvaro, Ph.D.; April Stanley, MS MBA
Pharma's Almanac
NI-8-26-MA43Aug 28, 2026
OSD
Advanced Oral Solid Dose Manufacturing Technologies
David Alvaro, Ph.D.; April Stanley, MS MBA
Pharma's Almanac
NI-8-26-MA14Aug 28, 2026
Market Drivers
Market Drivers for Small Molecule Therapeutics
David Alvaro, Ph.D.; April Stanley, MS MBA
Pharma's Almanac
NI-8-26-MA39Aug 27, 2026
sterile / market
Foundations of the Sterile Injectable Drugs Market
David Alvaro, Ph.D.; April Stanley, MS MBA
Pharma's Almanac
NI-8-26-MA21Aug 27, 2026
antibody / sterile
Impact of High Concentration Antibody Products on Formulation and Manufacturing
Amelia Hepworth; April Stanley, MS MBA
Nice Insight
NI-8-26-MA23Aug 27, 2026
Small molecules
Small Molecule API Regulatory Trends
David Alvaro, Ph.D.; April Stanley, MS MBA
Pharma's Almanac
NI-8-26-MA51Aug 27, 2026
Viral vectors
Introduction to Viral Vectors for Gene Therapy
April Stanley, MS MBA
Nice Insight
NI-8-26-MA41Aug 27, 2026
OSD
Introduction to Oral Solid Dose
David Alvaro, Ph.D.; April Stanley, MS MBA
Pharma's Almanac
NI-8-26-MA6Aug 27, 2026
mRNA / Analytics
Analytical Landscape of Viral Vectors
April Stanley, MS MBA
Nice Insight
NI-8-26-MA44Aug 27, 2026
Market Drivers
mRNA Therapeutics Market
April Stanley, MS MBA
Nice Insight
NI-8-28-MA-22Aug 27, 2026
Patent Landscape
The Patent Landscape and its Implications: Cell and Gene Therapies
April Stanley, MS MBA
Nice Insight
NI-8-26-MA27Aug 26, 2026
Market Drivers
Market Drivers of the RNA Landscape
April Stanley, MS MBA; David Alvaro, Ph.D.
Nice Insight
NI-8-26-MA20Aug 26, 2026
Market Drivers
Global Antibody-Drug Conjugate (ADC) Market Trends
April Stanley, MS MBA
Nice Insight
NI-8-26-MA-16Aug 26, 2026